Ki-67, as an easily assessed and reproducible proliferation factor, may be complement to histological grade as a prognostic tool for selection of adjuvant and treatment, which is a robust cost-effective diagnostic tool that subdivides grade 2 carcinomas into low and high risk populations providing additional prognostic information in planning and outcome prediction therapies [21]. Here, MKI67 is linked to carcinoma.